Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing
- PMID: 21114510
- DOI: 10.1111/j.1365-2265.2010.03935.x
Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing
Abstract
Objective: The diagnosis of growth hormone deficiency (GHD) in adults is established through growth hormone (GH) stimulation testing, which is often complex, expensive, time-consuming and may be associated with adverse side effects. The decision to perform GH provocative testing is influenced by clinical findings, medical history and biochemical evidence. We report in this study our experience using the glucagon stimulation test (GST) in assessing GHD in adult patients with traumatic brain injury (TBI) as it relates to baseline serum insulin-like growth factor-1 (IGF-1) concentrations.
Design: A receiver operating characteristic (ROC) curve analysis was performed to determine the optimal IGF-1 cut-off for diagnosis of GHD at different potential diagnostic GST cut-off values (<3, <5, & <10 μg/l).
Patients: One hundred and thirty-eight patients (98 men and 40 women) with a documented history of moderate to severe TBI were assessed for GHD using serum IGF-1 concentrations and the GST.
Measurements: IGF-1 values were compared with peak GH values obtained following the GST.
Results: An IGF-1 cut-off value of 175 μg/l minimized the misclassification of GHD patients and GH-sufficient patients and provided a sensitivity of 83% and specificity of 40%, as well as a negative predictive power of 90% considering a criterion for peak GH response of <3 μg/l.
Conclusions: Our current findings are consistent with previous work assessing peak GH response using the insulin tolerance test (ITT) in a non-TBI sample, suggesting that diagnostic accuracy may be optimized if the GST is used when obtained serum IGF-1 concentrations are below 175 μg/l. While the decision to perform provocative testing to assess GHD in adult patients should be based on the clinician's clinical impression, the findings from this retrospective study can provide useful clinical information and serve as a guide.
© 2011 Blackwell Publishing Ltd.
Similar articles
-
Growth hormone and adrenal response to intramuscular glucagon test and its relationship to IGF-1 production and left ventricular ejection fraction in adult B-thalassemia major patients.Pediatr Endocrinol Rev. 2011 Mar;8 Suppl 2:290-4. Pediatr Endocrinol Rev. 2011. PMID: 21705980 Clinical Trial.
-
Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.J Ayub Med Coll Abbottabad. 2009 Jul-Sep;21(3):40-5. J Ayub Med Coll Abbottabad. 2009. PMID: 20929010
-
Neuroendocrine dysfunction in the acute phase of traumatic brain injury.Clin Endocrinol (Oxf). 2004 May;60(5):584-91. doi: 10.1111/j.1365-2265.2004.02023.x. Clin Endocrinol (Oxf). 2004. PMID: 15104561
-
Update on epidemiology, etiology, and diagnosis of adult growth hormone deficiency.J Endocrinol Invest. 2008 Sep;31(9 Suppl):6-11. J Endocrinol Invest. 2008. PMID: 19020378 Review.
-
Diagnosis of adult GH deficiency.Growth Horm IGF Res. 2008 Feb;18(1):1-16. doi: 10.1016/j.ghir.2007.07.004. Epub 2007 Sep 4. Growth Horm IGF Res. 2008. PMID: 17766155 Review.
Cited by
-
Utility of serum IGF-1 for diagnosis of growth hormone deficiency following traumatic brain injury and sport-related concussion.BMC Endocr Disord. 2018 Apr 2;18(1):20. doi: 10.1186/s12902-018-0247-1. BMC Endocr Disord. 2018. PMID: 29609574 Free PMC article.
-
Chronic Hypopituitarism Associated with Increased Postconcussive Symptoms Is Prevalent after Blast-Induced Mild Traumatic Brain Injury.Front Neurol. 2018 Feb 19;9:72. doi: 10.3389/fneur.2018.00072. eCollection 2018. Front Neurol. 2018. PMID: 29515515 Free PMC article.
-
IGF-1 as a Biomarker for Symptom Severity in Adult Traumatic Brain Injury: Evidence from an Observational Study.Neurotrauma Rep. 2025 Apr 21;6(1):345-354. doi: 10.1089/neur.2025.0009. eCollection 2025. Neurotrauma Rep. 2025. PMID: 40697802 Free PMC article.
-
Acute and chronic hypopituitarism following traumatic brain injury: a systematic review and meta-analysis.Neurosurg Rev. 2024 Nov 11;47(1):841. doi: 10.1007/s10143-024-03088-3. Neurosurg Rev. 2024. PMID: 39527353 Free PMC article.
-
Systemic IGF-1 administration prevents traumatic brain injury induced gut permeability, dysmorphia, dysbiosis, and the increased number of immature dentate granule cells.Acta Neuropathol Commun. 2025 May 3;13(1):90. doi: 10.1186/s40478-025-01998-x. Acta Neuropathol Commun. 2025. PMID: 40319295 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous